Baird Financial Group, Inc. - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 170 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.

Quarter-by-quarter ownership
Baird Financial Group, Inc. ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$1,763,000
+6.9%
36,747
+2.5%
0.01%
-12.5%
Q1 2020$1,649,000
-23.2%
35,837
+0.2%
0.01%0.0%
Q4 2019$2,148,000
+20.0%
35,749
+13.0%
0.01%
+14.3%
Q3 2019$1,790,000
+5.6%
31,642
+4.0%
0.01%0.0%
Q2 2019$1,695,000
+4.6%
30,432
-5.2%
0.01%
-22.2%
Q1 2019$1,620,000
+17.7%
32,085
-6.1%
0.01%0.0%
Q4 2018$1,376,000
-40.7%
34,164
-0.3%
0.01%
-40.0%
Q3 2018$2,320,000
-9.2%
34,251
+1.4%
0.02%
-11.8%
Q2 2018$2,554,000
+43.7%
33,762
+0.1%
0.02%
+30.8%
Q1 2018$1,777,000
-1.1%
33,718
+0.3%
0.01%0.0%
Q4 2017$1,796,000
-10.7%
33,613
-0.3%
0.01%
-13.3%
Q3 2017$2,011,000
-24.8%
33,717
-0.5%
0.02%
-28.6%
Q2 2017$2,673,000
-5.1%
33,887
-0.3%
0.02%
-8.7%
Q1 2017$2,818,000
+5.9%
33,973
+1.3%
0.02%0.0%
Q4 2016$2,660,00033,5220.02%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Hudson Executive Capital LP 1,323,794$79,534,0003.54%
Park West Asset Management LLC 1,171,880$70,406,0002.96%
Matarin Capital Management, LLC 170,008$10,214,0000.98%
Smith, Graham & Co., Investment Advisors, LP 140,014$8,412,0000.82%
Capital Impact Advisors, LLC 33,725$2,026,0000.71%
U S GLOBAL INVESTORS INC 18,800$1,130,0000.51%
CHARTWELL INVESTMENT PARTNERS, LLC 187,989$11,294,0000.37%
Stanley-Laman Group, Ltd. 24,000$1,442,0000.34%
GLOBEFLEX CAPITAL L P 18,751$1,127,0000.21%
Foundry Partners, LLC 70,357$4,227,0000.16%
View complete list of EAGLE PHARMACEUTICALS INC shareholders